2024
Management of Incomplete Microcirculatory Reperfusion After Endovascular Thrombectomy: Focus on Inhibition of the Glycoprotein IIb/IIIa Receptor Pathway
Krothapalli N, Ortel T, McBride D, de Havenon A, Sansing L, Hasan D, Mac Grory B. Management of Incomplete Microcirculatory Reperfusion After Endovascular Thrombectomy: Focus on Inhibition of the Glycoprotein IIb/IIIa Receptor Pathway. Stroke Vascular And Interventional Neurology 2024, 4 DOI: 10.1161/svin.123.001048.Peer-Reviewed Original ResearchMicrocirculatory reperfusionEndovascular thrombectomyAdministration of tirofibanDigital subtraction angiographyLarge-vessel occlusionProportion of casesRescue therapyTherapeutic optionsAntiplatelet therapyClinical outcomesUnfavorable outcomeEndothelial edemaSubtraction angiographyEffective therapyIntraarterial administrationClinical challengeReceptor pathwayPlatelet aggregationTreatment approachesTherapyReperfusionCerebral microvasculatureTissue recoveryNeurological diseasesThrombectomy
2011
The Secret “Spice”: An Undetectable Toxic Cause of Seizure
de Havenon A, Chin B, Thomas KC, Afra P. The Secret “Spice”: An Undetectable Toxic Cause of Seizure. The Neurohospitalist 2011, 1: 182-186. PMID: 23983854, PMCID: PMC3726077, DOI: 10.1177/1941874411417977.Peer-Reviewed Original ResearchFirst generalized seizureEmergency department physiciansGeneralized seizuresDepartment physiciansSide effectsSynthetic cannabinoidsEmergency department visitsTonic-clonic seizuresCannabinoid receptors CB1US Drug Enforcement AdministrationToxic side effectsProconvulsant effectsProvoked seizuresDepartment visitsAntiepileptic drugsToxic causesUnnecessary treatmentDifferential diagnosisPrior historyDrug toxicityReceptors CB1Detailed historyNeurological diseasesSeizuresSynthetic cannabinoid products